Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gliclazide hydroxylation by rat liver microsomes

A Rieutord1, I Stupans, G M Shenfield

  • 1Department of Clinical Pharmacology, Royal North Shore Hospital, St Leonards, NSW, Australia.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|December 1, 1995
PubMed
Summary

Gliclazide metabolism in rats involves at least two cytochrome P450 enzymes, CYP2D1 and tolbutamide hydroxylase. These enzymes show similar affinities for gliclazide, indicating a complex metabolic pathway for this drug.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.

European journal of cancer (Oxford, England : 1990)·2024
Same author

A metabolite sensor subunit of the Atg1/ULK complex regulates selective autophagy.

Nature cell biology·2024
Same author

Knowledge exchange between patient and pharmacist: A mixed methods study to explore the role of pharmacists in patient education and counseling in asthma and pulmonary arterial hypertension.

Annales pharmaceutiques francaises·2022
Same author

[Pharmaceutical cares as means of prevention against drug iatrogenic: Case of oral anticoagulant].

Annales pharmaceutiques francaises·2021
Same author

Evaluation of a program of pharmaceutical counseling for French patients on oral anticoagulant therapy.

International journal of clinical pharmacy·2020
Same author

[Design and assessment of a outpatient living with PICC-line support program: A pilot study].

Annales pharmaceutiques francaises·2018

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Biochemistry

Background:

  • Gliclazide is a sulfonylurea drug used to treat type 2 diabetes.
  • Understanding its metabolic pathways is crucial for predicting drug interactions and optimizing therapy.

Purpose of the Study:

  • To investigate the metabolism of gliclazide in Sprague-Dawley rat liver microsomes.
  • To identify the specific cytochrome P450 (CYP) isoforms involved in gliclazide hydroxylation.
  • To characterize the kinetic parameters and inhibitory profiles of gliclazide metabolism.

Main Methods:

  • Incubation of gliclazide with rat liver microsomes.
  • Kinetic analysis using Michaelis-Menten models.
  • Inhibition studies with various drug compounds.

Related Experiment Videos

  • Correlation analysis with CYP2D1 activity markers.

    • Main Results:

    • Gliclazide metabolism follows Michaelis-Menten kinetics with an apparent K(m) of 256 ± 27 μM.
    • Tolbutamide and gliclazide competitively inhibited each other's hydroxylation, suggesting shared metabolic enzymes.
    • Diclofenac, phenytoin, mephenytoin, glibenclamide, and glipizide were competitive inhibitors of gliclazide hydroxylation.
    • Quinine and quinidine showed partial competitive inhibition.
    • Gliclazide hydroxylation correlated significantly with CYP2D1 activity (rs = 0.83, p = 0.01).

    Conclusions:

    • Gliclazide is metabolized to hydroxygliclazide by at least two CYP isoforms in rats: tolbutamide hydroxylase and CYP2D1.
    • These isoforms exhibit similar affinities for gliclazide.
    • The findings highlight the potential for drug-drug interactions involving gliclazide and other CYP-metabolized drugs.